financetom
Business
financetom
/
Business
/
Lose Weight With Novo Nordisk Drugs, Gain Money With Stock
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lose Weight With Novo Nordisk Drugs, Gain Money With Stock
Sep 25, 2024 4:54 PM

Some experts believe Novo Nordisk ( NVO ) A/S products not only help people lose weight and control diabetes, they can help treat the country’s addiction crisis.

The Novo Nordisk chart illustrates two common technical analysis dynamics that successful traders can use to profit.

As you can see, the $123 level was support for the stock in April. Then it was support again in early August. And after a recent move higher and a reversal, the stock found support around the same level again.

Support can stay intact for an extended time because of investor and trader psychology. It is because there are traders who sold while the stock was at support. But right after they were done selling, the shares rallied.

When this happened, many of these sellers came to regret their decision to get rid of their shares. Some of them decided to buy their shares back. But, they will only do so if they can buy the shares for the same price they were sold.

Read Also: Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users

So, when the stock reversed and eventually returned to the support level, these remorseful sellers placed buy orders. And there were so many of these buy orders that it created support at the level which had been support before.

Seller's remorse can make support levels stay intact for an extended period of time.

When a stock drops to a support level, there is a tendency for them to reverse and rally. This is also because of psychology. It happens because some of the buyers experience anxiety.

These buyers are worried they will miss the trade. They know that the sellers will go to whoever is willing to pay the highest price.

As a result, they increase the prices they are willing to pay. Other anxious buyers see this and do the same thing.

This results in a bidding war that pushes the price higher.

If understood and interpreted correctly, technical analysis is the study of investor and trader psychology. Seller's remorse can cause support levels to stay intact for an extended period of time. Buyer's anxiety can make stocks rally after the drop to support levels.

Read Next:

• Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Incyte Says FDA Extends Review Period for Ruxolitinib Cream
Incyte Says FDA Extends Review Period for Ruxolitinib Cream
Jun 20, 2025
04:49 PM EDT, 06/20/2025 (MT Newswires) -- Incyte ( INCY ) said Friday the US Food and Drug Administration has extended the review period for the supplemental new drug application for ruxolitinib cream to treat children with mild to moderate atopic dermatitis. The prescription drug user fee act action date has been extended to Sept. 19, Incyte ( INCY )...
Ensign Group Insider Sold Shares Worth $731,445, According to a Recent SEC Filing
Ensign Group Insider Sold Shares Worth $731,445, According to a Recent SEC Filing
Jun 20, 2025
04:48 PM EDT, 06/20/2025 (MT Newswires) -- Beverly B. Wittekind, Vice President and Chief Legal Officer, on June 18, 2025, sold 4,719 shares in Ensign Group ( ENSG ) for $731,445. Following the Form 4 filing with the SEC, Wittekind has control over a total of 38,679 common shares of the company, with 38,679 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1125376/000112537625000117/xslF345X05/wk-form4_1750452238.xml...
Verisign Insider Sold Shares Worth $2,545,871, According to a Recent SEC Filing
Verisign Insider Sold Shares Worth $2,545,871, According to a Recent SEC Filing
Jun 20, 2025
04:47 PM EDT, 06/20/2025 (MT Newswires) -- D James Bidzos, Director, Executive Chairman, President, & CEO, on June 17, 2025, sold 9,000 shares in Verisign ( VRSN ) for $2,545,871. Following the Form 4 filing with the SEC, Bidzos has control over a total of 531,772 common shares of the company, with 531,772 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1014473/000120481625000014/xslF345X05/wk-form4_1750452253.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved